Clinical Observation on the Treatment of Atrial Fibrillation with Amiodarone Combined with Shenmai Injection (sic)

被引：12

作者：

Deng Min ^{[1
]}

Sui Xiang-qian ^{[1
]}

Zhu Shi-bing ^{[1
]}

Ma Wei ^{[1
]}

Xu Ying ^{[1
]}

Chen Zhi-ming ^{[1
]}

机构：

[1] Zhejiang Univ Tradit Chinese Med, Dept Emergency Med, Integrated Chinese & Western Med Hosp, Hangzhou 310003, Zhejiang, Peoples R China

来源：

CHINESE JOURNAL OF INTEGRATIVE MEDICINE | 2010年 / 16卷 / 05期

关键词：

atrial fibrillation; amiodarone; Shenmai Injection; HEART-FAILURE;

D O I：

10.1007/s11655-010-0540-y

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

Objective: To observe the therapeutic efficacy and safety of amiodarone combined with Shenmai Injection (sic) on atrial fibrillation. Methods: A total of 351 patients with atrial fibrillation caused by cardiovascular diseases and idiopathic atrial fibrillation were assigned to amiodarone group (control group, 128 cases) and amiodarone combined with Shenmai Injection group (treatment group, 223 cases). The patients in the control group received intravenous injection of 150 mg amiodarone in 10 min, followed by intravenous drip infusion at 1 mg/min and 6 h later at 0.5 mg/min until 48 h or cardioversion. The patients in the treatment group received the same treatment of amiodarone, while in addition, they received an injection of Shenmai Injection of 100 mL simultaneously. Blood pressure, ventricular rate, and cardioversion were observed. Results: The total efficiency rate was 98% (control group) and 99% (treatment group) (P>0.05). The mean ventricular rate decreased 23% and 31% in the control group and the treatment group, respectively (P<0.05). The mean cardioversion time of the two groups was 570 +/- 211 min and 351 +/- 123 min, respectively (P<0.05). Only mild side effects were observed in both groups. Conclusion: Compared with amiodarone, amiodarone combined with Shenmai Injection takes effect more quickly with low side effects on the treatment of atrial fibrillation.

引用

页码：453 / 456

页数：4

共 15 条

[1]

CHEN X, 2000, CLIN ARRHYTHMOLOGY E, P780

[2] Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation [J].

Cybulski, J ;

Kulakowski, P ;

Budaj, A ;

Danielewicz, H ;

Maciejewicz, J ;

Kawka-Urbanek, T ;

Ceremuzynski, L .

CLINICAL CARDIOLOGY, 2003, 26 (07) :329-335

[3] ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, David S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Le Heuzey, Jean-Yves ;

Kay, G. Neal ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, Samuel .

CIRCULATION, 2006, 114 (07) :E257-E354

[4] Clinical Outcome of Patients with Heart Failure and Preserved Left Ventricular Function [J].

Gotsman, Israel ;

Zwas, Donna ;

Planer, David ;

Azaz-Livshits, Tanya ;

Admon, Dan ;

Lotan, Chaim ;

Keren, Andre .

AMERICAN JOURNAL OF MEDICINE, 2008, 121 (11) :997-1001

[5]

JIA LW, 1998, INTEGR TRADIT CHIN W, V5, P40

[6]

LI H, 2008, J PRACT TRADIT CHIN, V22, P25

[7]

LI YL, 2000, ACAD PERIODICAL CHAN, V16, P16

[8]

LIU M, 1998, CHIN J INF TRADIT ME, V5, P58

[9] β-blockers are effective in congestive heart failure patients with atrial fibrillation [J].

Meng, FB ;

Yoshikawa, T ;

Baba, A ;

Moritani, K ;

Suzuki, M ;

Satoh, T ;

Yokozuka, H ;

Murayama, A ;

Ogawa, S .

JOURNAL OF CARDIAC FAILURE, 2003, 9 (05) :398-403

[10] Hybrid therapy of atrial fibrillation: Algorithms and outcome [J].

Saksena, S ;

Madan, N .

JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2003, 9 (02) :235-247

← 1 2 →